Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
大うつ病性障害の治療における(11β,17β)-11-(1,3-ベンゾジオキソール-5-イル)-17-ヒドロキシ-17-(1-プロピニル)エストラ-4,9-ジエン-3-オンの使用
Document Type and Number:
Japanese Patent JP4647909
Kind Code:
B2
Abstract:
The present invention relates to the use of the glucocorticoid receptor antagonist (11²,17²)-11-(1,3-benzodioxol-5-yl)-17-hydroxy-17-(1-propynyl)estra-4,9-dien-3-one (Org 34517) for the preparation of a medicament for the treatment of depression as well as to pharmaceutical preparations of Org 34517 for said use.

Inventors:
Senef, Cornelis
Peters, Bernardus Weinand Matthews Marie
Application Number:
JP2003539697A
Publication Date:
March 09, 2011
Filing Date:
October 21, 2002
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
Narmrose Fuennault Chap Organon
International Classes:
A61K31/58; A61P25/24; C07J9/00; C07J17/00
Domestic Patent References:
JP2001518509A
JP9104696A
Other References:
Bachmann, C.G. et al.,European Neuropsychopharmacology,2000年,Vol.10, Suppl.3,pp.S271-S272
PEARSON MURPHY B E,CANADIAN JOURNAL OF PSYCHIATRY. REVUE CANADIENNE DE PSYCHIATRIE,カナダ,CANADIAN PSYCHIATRIC ASSOCIATION,1998年 4月,V43,P279-286
Attorney, Agent or Firm:
Yoshio Kawaguchi
Makoto Ono
Chihiro Watanabe
Kenkyo Kanayama
Katsuma Osaki
Mitsuaki Tsubokura